Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Axsome Therapeutics, Inc. - Common Stock (NQ:AXSM)

105.45 +1.54 (+1.48%)
Streaming Delayed Price Updated: 1:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Axsome Therapeutics, Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
22 23 Next >
Why Is Xponential Fitness (XPOF) Stock Up 19% Today?
Xponential Fitness (XPOF) stock is climbing higher on Wednesday as the company strikes back against a short report from Fuzzy Panda Research. 
Via InvestorPlace
Why Is Axsome Therapeutics (AXSM) Stock Down 10% Today?
Axsome Therapeutics (AXSM) stock is heading lower on Wednesday as investors react to the company pricing a public share offering. 
Via InvestorPlace
Axsome Therapeutics Announces Pricing of Public Offering of $225 Million of Shares of Common Stock
From Axsome Therapeutics, Inc.
Via GlobeNewswire
As the Bull Roars, Shareholders Hate How These 2 Companies Are Selling Their Stock
Markets could have a tough time building on gains from Tuesday. 
Via The Motley Fool
2 Under-the-Radar Biotech Stocks to Buy in 2023
These companies are coming into their own. 
Via The Motley Fool
Where Will Axsome Therapeutics Be in 3 Years?
The stock soared more than 100% last year. 
Via The Motley Fool
This Stock Crushed the Market Last Year. Here's Why It Could Do That Again.
This small biotech could become much bigger in just a few years. 
Via The Motley Fool
Axsome Therapeutics Stock Is Moving Lower: What's Going On?
Axsome Therapeutics Inc (NASDAQ: AXSM) shares are trading lower Wednesday after the company proposed a public offering of common stock. 
Via Benzinga
The Best Stocks to Invest $20,000 in Right Now
You can invest in these companies with $20,000 -- or even a lot less. 
Via The Motley Fool
Axsome Therapeutics Announces Proposed Public Offering of Common Stock
From Axsome Therapeutics, Inc.
Via GlobeNewswire
2 Low-Priced Stocks That Could Make You Richer
These two low-priced healthcare stocks could skyrocket within the next 12 months. 
Via The Motley Fool
3 Monster Stocks in the Making to Buy Right Now
They're not monsters now -- but just give them some time. 
Via The Motley Fool
Is Axsome Therapeutics Stock a Screaming Buy?
The biotech could be staring down an enormous commercial opportunity. 
Via The Motley Fool
Why Axsome Therapeutics Stock Is Rising Today
Axsome Therapeutics, Inc. (NASDAQ: AXSM) shares are trading higher Wednesday following a recent corporate presentation. 
Via Benzinga
Analyst Expectations for Axsome Therapeutics's Future
Via Benzinga
3 Biotech Stocks to Buy as Companies Ink Major Deals
Pharmaceutical and biotech companies will soon face generic competition, creating big opportunity for these top biotech stocks to buy. 
Via InvestorPlace
Does an $11.5 Billion Opportunity Make This Growth Stock a Buy Now?
Soaring sales of a new depression treatment could be just the tip of the iceberg for Axsome Therapeutics. 
Via The Motley Fool
Stock Market Rally Runs Through Hawkish Fed; Adobe, Lennar, Oracle, UnitedHealth In Focus: Weekly Review
Stocks kept powering higher despite, but the Nasdaq is looking extended. 
Via Investor's Business Daily
Axsome Therapeutics Expects Up To $11.5 Billion In Peak Sales, Wallops Analysts' Forecasts
The company's biggest products treats depression and could be used in other conditions. 
Via Investor's Business Daily
3 No-Brainer Stocks to Buy in June
These biopharma stocks could be big winners. 
Via The Motley Fool
Axsome Therapeutics's Return On Capital Employed Overview
Via Benzinga
The Top Healthcare Stocks to Buy With $100
You don't need a fortune to start investing. 
Via The Motley Fool
Axsome Therapeutics to Present New Sunosi® Data at SLEEP 2023
Cognitive improvement with Sunosi sustained over eight hours in patients with excessive daytime sleepiness due to obstructive sleep apnea 
From Axsome Therapeutics, Inc.
Via GlobeNewswire
Axsome Therapeutics to Present Data and Post-Hoc Analyses on Auvelity® and Sunosi® at the 2023 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
From Axsome Therapeutics, Inc.
Via GlobeNewswire
Prediction: These 2 Stocks Could Double In the Next Year
It would be a continuation of solid recent performances. 
Via The Motley Fool
2 Biotech Stocks That Could Help Set You Up for Life
These two promising companies have the potential to beat the market over time. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
2 Bear Market Defying Stocks to Buy in May
These stocks still have plenty of market-beating years ahead. 
Via The Motley Fool
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond
Both Axsome Therapeutics and Exelixis have potentially game-changing products in their pipelines. 
Via The Motley Fool
Is a Victory for Its Rivals Bad News for Axsome Therapeutics?
The biopharmaceutical company's shares have soared during the past year. 
Via The Motley Fool
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback